View of IDENTIFICATION OF SB216763 AS A PROMISING TARGETED THERAPY FOR POOR-PROGNOSIS CHOLANGIOCARCINOMA PATIENTS

Return to Article Details IDENTIFICATION OF SB216763 AS A PROMISING TARGETED THERAPY FOR POOR-PROGNOSIS CHOLANGIOCARCINOMA PATIENTS Download Download PDF